Beck Depression Inventory | Rehab Centers Network

Beck Depression Inventory

Neurobehavioral and Genotoxic Evaluation of (-)-Linalool in Mice.

Published February 27, 2013

Neurobehavioral and genotoxic evaluation of (-)-linalool in mice.

J Nat Med. 2013 Feb 24;
Coelho V, Mazzardo-Martins L, Martins DF, Santos AR, da Silva Brum LF, Picada JN, Pereira P

(-)-Linalool is a monoterpene compound commonly found as a… Continue reading →

Leptin and Its Association With Somatic Depressive Symptoms in Patients With the Metabolic Syndrome.

Published February 27, 2013

Leptin and its Association with Somatic Depressive Symptoms in Patients with the Metabolic Syndrome.

Ann Behav Med. 2013 Feb 23;
Chirinos DA, Goldberg R, Gellman M, Mendez AJ, Gutt M, McCalla JR, Llabre MM, Schneiderman N

BACKGROUND: This study… Continue reading →

Psychiatric Consequences of Needlestick Injury.

Published February 24, 2013

Psychiatric consequences of needlestick injury.

Occup Med (Lond). 2013 Feb 21;
Green B, Griffiths EC

BackgroundNeedlestick injuries (NSIs) are a common occupational hazard with potential physical health effects, including viral infections such as hepatitis and HIV. Less appreciated are… Continue reading →

Hippocampal Abnormalities of Glutamate/glutamine, N-Acetylaspartate and Choline in Patients With Depression Are Related to Past Illness Burden.

Published February 22, 2013

Hippocampal abnormalities of glutamate/glutamine, N-acetylaspartate and choline in patients with depression are related to past illness burden.

J Psychiatry Neurosci. 2013 Mar; 38(2): 107-16
de Diego-Adeliño J, Portella MJ, Gómez-Ansón B, López-Moruelo O, Serra-Blasco M, Vives Y, Puigdemont D,… Continue reading →

Depression Treatment: Family-Based Study of AVPR1B Association and Interaction With Stressful Life Events on Depression and Anxiety in Suicide Attempts.

Published February 22, 2013

Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts.

Filed under: Depression Treatment

Neuropsychopharmacology. 2013 Feb 19;
Ben-Efraim YJ, Wasserman D, Wasserman J, Sokolowski M

The cortisol response to psychosocial… Continue reading →

Improving the Treatment of Parkinson’s Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Published February 21, 2013

Improving the Treatment of Parkinson’s Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Filed under: Depression Treatment

Aging Dis. 2013 Feb; 4(1): 1-13
Shimizu S, Ohno Y

Parkinson’s disease, the most common neurological disorder in the elderly, is characterized… Continue reading →

Emotional Distress Among Caregivers of Patients With Epilepsy in Katsina State, Northern Nigeria.

Published February 19, 2013

Emotional distress among caregivers of patients with epilepsy in Katsina State, Northern Nigeria.

Filed under: Depression Treatment

Afr J Psychiatry (Johannesbg). 2013 Jan; 16(1): 41-44
Yusuf AJ, Nuhu FT, Olisah VO

OBJECTIVE: Caregivers of patients with epilepsy experience onsiderable… Continue reading →

Acceptance and Commitment Therapy as a Treatment for Scrupulosity in Obsessive Compulsive Disorder.

Published February 14, 2013

Acceptance and Commitment Therapy as a Treatment for Scrupulosity in Obsessive Compulsive Disorder.

Filed under: Depression Treatment

Behav Modif. 2013 Feb 11;
Dehlin JP, Morrison KL, Twohig MP

This study evaluated acceptance and commitment therapy (ACT) for scrupulosity-based obsessive… Continue reading →

CPAP Therapy in Patients With Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: Does It Offer a Better Quality of Life and Sleep?

Published February 8, 2013

CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?

Filed under: Depression Treatment

Sleep Breath. 2013 Feb 6;
Mermigkis C, Bouloukaki I, Antoniou KM, Mermigkis D,… Continue reading →

Drug and Alcohol Rehabilitation: Therapeutic Application of Melatonin in Mild Cognitive Impairment.

Published February 6, 2013

Therapeutic application of melatonin in mild cognitive impairment.

Filed under: Drug and Alcohol Rehabilitation

Am J Neurodegener Dis. 2012; 1(3): 280-91
Cardinali DP, Vigo DE, Olivar N, Vidal MF, Furio AM, Brusco LI

Mild cognitive impairment (MCI) is an… Continue reading →

Call Now!

X